Aberdeen Group
HZNP

Aberdeen Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-40,812
Closed -$4.72M 993
2023
Q3
$4.72M Sell
40,812
-16,941
-29% -$1.96M 0.01% 564
2023
Q2
$5.94M Sell
57,753
-103,911
-64% -$10.7M 0.01% 549
2023
Q1
$17.6M Sell
161,664
-1,684,822
-91% -$184M 0.04% 369
2022
Q4
$210M Sell
1,846,486
-69,431
-4% -$7.9M 0.57% 36
2022
Q3
$119M Sell
1,915,917
-183,607
-9% -$11.4M 0.35% 64
2022
Q2
$171M Buy
2,099,524
+10,798
+0.5% +$878K 0.54% 41
2022
Q1
$221M Buy
2,088,726
+258,346
+14% +$27.4M 0.57% 40
2021
Q4
$197M Sell
1,830,380
-42,486
-2% -$4.58M 0.43% 58
2021
Q3
$205M Buy
1,872,866
+56,265
+3% +$6.16M 0.46% 52
2021
Q2
$170M Sell
1,816,601
-77,600
-4% -$7.27M 0.37% 67
2021
Q1
$174M Buy
1,894,201
+134,636
+8% +$12.4M 0.4% 66
2020
Q4
$129M Sell
1,759,565
-284,978
-14% -$20.8M 0.31% 79
2020
Q3
$159M Sell
2,044,543
-78,734
-4% -$6.12M 0.42% 64
2020
Q2
$118M Sell
2,123,277
-146,241
-6% -$8.12M 0.32% 82
2020
Q1
$67.2M Buy
2,269,518
+429,800
+23% +$12.7M 0.21% 99
2019
Q4
$66.6M Buy
1,839,718
+346,321
+23% +$12.5M 0.16% 111
2019
Q3
$40.7M Buy
+1,493,397
New +$40.7M 0.1% 169